Literature DB >> 938946

Regional study of cerebral ventricle sensitive sites to angiotensin II.

W E Hoffman, M I Phillips.   

Abstract

Angiotensin II injected in small doses into the cerebral ventricles produces an increase in blood pressure and drinking behavior. The site of action for both of these effects was studied in 3 main experiments. (1) The response to several doses of angiotensin delivered to each ventricle was investigated with multiple ventricular cannulation. This revealed that the rostral ventricular system was involved in angiotensin II mediated responses. (2) CSF flow was limited by plugging specific anterior and posterior ventricular regions and then testing for angiotensin II induced drinking and pressor responses. This technique showed that the ventral anterior third ventricle must be reached by the peptide in order to produce either blood pressure or drinking effects. (3) In order to separate pressor components due to vasopressin release and sympathetic activation, hypophysectomized rats were also tested. The experiment showed that the pressor response to intraventricular angiotensin II is due to both sympathetic and pituitary hormonal components and both are dependent on sites sensitive to angiotensin in the anterior third ventricule. The ventral anterior third ventricle or periventricular tissue surrounding it seems to be essential for both blood pressure and drinking responses to intraventricular angiotensin II.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 938946     DOI: 10.1016/0006-8993(76)90405-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

Review 1.  Humoral and neurohormonal aspects of blood pressure regulation: focus on angiotensin.

Authors:  D Ganten; G Stock
Journal:  Klin Wochenschr       Date:  1978

2.  Effects of intracerebroventricular injections of 5-HT on systemic vascular resistances of conscious rats.

Authors:  Robin L Davisson; James N Bates; Alan Kim Johnson; Stephen J Lewis
Journal:  Microvasc Res       Date:  2014-08-14       Impact factor: 3.514

3.  Endogenous angiotensin stimulation of vasopressin in the newborn lamb.

Authors:  S R Siegel; R E Weitzman; D A Fisher
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

4.  Increased hypothalamic signal transducer and activator of transcription 3 phosphorylation after hindbrain leptin injection.

Authors:  Marieke Ruiter; Patricia Duffy; Steven Simasko; Robert C Ritter
Journal:  Endocrinology       Date:  2010-02-25       Impact factor: 4.736

Review 5.  The renin-angiotensin system in the control of systemic arterial pressure.

Authors:  A B Ribeiro; O Kohlmann; M A Saragoça; O Marson; O L Ramos
Journal:  Drugs       Date:  1985       Impact factor: 9.546

6.  Drinking and haemodynamic changes induced in the dog by intracranial injection of components of the renin-angiotensin system.

Authors:  J T Fitzsimons; J Kucharczyk
Journal:  J Physiol       Date:  1978-03       Impact factor: 5.182

7.  Lithium-induced polydipsia: dependence on nigrostriatal dopamine pathway and relationship to changes in the renin-angiotensin system.

Authors:  R B Mailman
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

8.  The effect of analogues of angiotensin II on drinking and cardiovascular responses to central angiotensin II in the rat.

Authors:  L A Camargo; L A De Luca; J V Menani; A Renzi; W A Saad; W A Saad; J E Silveira
Journal:  J Physiol       Date:  1991-11       Impact factor: 5.182

9.  The anteroventral third ventricle region is critical for the behavioral desensitization caused by repeated injections of angiotensin II.

Authors:  Peter J Vento; Derek Daniels
Journal:  Behav Brain Res       Date:  2013-10-18       Impact factor: 3.332

10.  Mitogen-activated protein kinase is required for the behavioural desensitization that occurs after repeated injections of angiotensin II.

Authors:  Peter J Vento; Derek Daniels
Journal:  Exp Physiol       Date:  2012-05-11       Impact factor: 2.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.